AJP - Renal Physiology, Vol 267, Issue 2 197-F207, Copyright © 1994 by American Physiological Society

ARTICLES

Cytokines and L-arginine in renal injury and repair

M. Ketteler, W. A. Border and N. A. Noble

Advances in molecular biology have identified cytokines as mediators of pathophysiological changes in chronic renal disease. Transforming growth factor-beta (TGF-beta) plays an important role in the pathogenesis of glomerular and interstitial fibrosis, whereas platelet-derived growth factor (PDGF) is involved in proliferative changes in chronic progressive renal diseases. Tumor necrosis factor-alpha and interleukins are expressed in experimental models of renal disease and are causes of inflammation and cell migration. Cytokines act by many different mechanisms, and one target of their action may be L-arginine metabolism. Since the discovery of the effector molecule nitric oxide (NO), generated from L-arginine, knowledge of this pathway has increased dramatically. It became evident that the L-arginine/NO pathway is of major importance in the regulation of hemodynamics and neurotransmission, in host defense against intracellular microorganisms, and in immunologic tissue injury. This pathway is induced by proinflammatory cytokines and possibly regulated by TGF-beta and PDGF. L-Arginine is also metabolized to L-ornithine, which can be processed to polyamines or to L-proline. As polyamines are important mediators of cell growth and L-proline is a substrate for collagen synthesis, both pathways, once activated, may be important in repair processes. It is likely that cytokines and L-arginine metabolism are interconnected and that both are involved in the inflammation, tissue repair, and fibrogenesis processes in the kidney. Dietary protein restriction in progressive renal diseases may substantially affect both systems. This review summarizes current knowledge about interactions of cytokines and L-arginine metabolism and the relevance to renal diseases.

This article has been cited by other articles:

				M. Sabbatini, A. Pisani, F. Uccello, G. Fuiano, R. Alfieri, A. Cesaro, B. Cianciaruso, and V. E. Andreucci Arginase inhibition slows the progression of renal failure in rats with renal ablation Am J Physiol Renal Physiol, April 1, 2003; 284(4): F680 - F687. [Abstract] [Full Text] [PDF]

				S. Q. DOI, T. A. JACOT, D. F. SELLITTI, P. HIRSZEL, M. H. HIRATA, G. E. STRIKER, and L. J. STRIKER Growth Hormone Increases Inducible Nitric Oxide Synthase Expression in Mesangial Cells J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1419 - 1425. [Abstract] [Full Text]

				M. Liang and F. G. Knox Production and functional roles of nitric oxide in the proximal tubule Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1117 - R1124. [Abstract] [Full Text] [PDF]

				M. Ketteler, R. Westenfeld, A. Gawlik, E. de Heer, and A. Distler Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis Nephrol. Dial. Transplant., January 1, 2000; 15(1): 16 - 22. [Abstract] [Full Text] [PDF]

				J. Satriano, S. Ishizuka, D. C. Archer, R. C. Blantz, and C. J. Kelly Regulation of intracellular polyamine biosynthesis and transport by NO and cytokines TNF-alpha and IFN-gamma Am J Physiol Cell Physiol, April 1, 1999; 276(4): C892 - C899. [Abstract] [Full Text] [PDF]

				L. Balsam and N. Nikbakht L-Arginine inhibits vasopressin-stimulated mesangial cell Ca2+ Am J Physiol Cell Physiol, August 1, 1998; 275(2): C352 - C357. [Abstract] [Full Text] [PDF]

				N. Bouriquet, M. Dupont, A. Herizi, A. Mimran, and D. Casellas Preglomerular Sudanophilia in L-NAME Hypertensive Rats : Involvement of Endothelin Hypertension, March 1, 1996; 27(3): 382 - 391. [Abstract] [Full Text]